Chen Qian, PhD

Center for Inflammation & Epigenetics, Houston Methodist Hospital Research Institute, Houston, USA

Dr. Qian received his Bachelor’s degree in biochemistry in Nanjing University. Then he started the PhD research on cardiovascular disease, especially fibrinolysis pharmacology in the Institute of Molecular Medicine, Nanjing University and received his PhD in Biochemistry & Molecular Biology. After he joined in Houston Methodist Hospital Research Institute in 2013, he conducted research on three projects: 1) Screening on the immunogenicity of somatic mutations in multiple cancers. 2) Immunotherapy of melanoma with modified TCR and CAR. 3) Epigenetic regulation of cellular reprogramming of induced pluripotent stem cells (iPSCs).

Terms of Appointment: Feb 2016 - Dec 2019